Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation (Q39136453)
Jump to navigation
Jump to search
scientific article published on 20 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation |
scientific article published on 20 June 2013 |
Statements
1 reference
Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation (English)
1 reference
Yinqiang Xin
1 reference
Fei Yin
1 reference
Shimei Qi
1 reference
Lei Shen
1 reference
Yimiao Xu
1 reference
Lan Luo
1 reference
Lei Lan
1 reference
Zhimin Yin
1 reference
20 June 2013
1 reference
1 reference
221
1 reference
2
1 reference
73-82
1 reference
Identifiers
1 reference
1 reference